Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

GTX ( GTXI) is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that target hormone pathways for the treatment of cancer, cancer supportive care, and other serious medical conditions. This stock is trading up 4.9% at $3.61 in recent trading.

Today's Range: $3.44-$3.66

52-Week Range: $2.34-$6.55

Volume: 73,000

Three-Month Average Volume: 141,756

>>22 Biopharma Stocks With Breakout Potential in 2012

From a technical perspective, GTXI is jumping higher here back above its 200-day moving average of $3.56 with light volume. This move is quickly pushing GTXI within range of triggering a major breakout trade. That trade will trigger once GTXI takes out some near-term overhead resistance levels at $3.83 to $3.92, and then over some past resistance at $4.07 with high volume.

Traders should now look for long-biased trades in GTXI if it can sustain a move or close above those levels with volume that's near or above 141,756 shares. Traders could also look for long-biased trades in GTXI as long as it's trending above some near-term support at $3.30 a share, and simply anticipate that breakout. If that breakout triggers soon, then GTXI could be well on its way towards filling some of its previous gap down from February that started at around $5.75.

If you liked this article you might like

Cyclacel Stock Runs on Momentum Rocket Fueled by 'Dumb & Dumber' Optimism

Insider Trading Alert - PODD, POWI And SNSS Traded By Insiders

5 Stocks Under $10 Set to Soar

4 Biotech Stocks Under $10 to Trade for Breakouts

Analysts' Actions -- Cigna, Monster Beverage, Qualcomm and More